StockDriftsStockDriftsTop 25 Camber Capital Management Lp Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 29% | 500.0K | $308.9M | -66.67%(-1.00M) | — | 2025-06-30 | |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 8.56% | 1.00M | $91.2M | -55.56%(-1.25M) | — | 2025-06-30 | |
| BAX | BAXTER INTL INC | 8.1% | 2.85M | $86.3M | -50.43%(-2.90M) | — | 2025-06-30 | |
| HUM | HUMANA INC | 6.89% | 300.0K | $73.3M | -58.62%(-425.00K) | — | 2025-06-30 | |
| CVS | CVS HEALTH CORP | 6.8% | 1.05M | $72.4M | -53.33%(-1.20M) | — | 2025-06-30 | |
| GMED | GLOBUS MED INC | 4.43% | 800.0K | $47.2M | -36.00%(-450.00K) | — | 2025-06-30 | |
| ICLR | ICON PLC | 4.1% | 300.0K | $43.6M | new | — | 2025-06-30 | |
| ASND | ASCENDIS PHARMA A/S | 4.05% | 250.0K | $43.1M | -28.57%(-100.00K) | — | 2025-06-30 | |
| MRK | MERCK & CO INC | 3.72% | 500.0K | $39.6M | -66.67%(-1.00M) | — | 2025-06-30 | |
| GSK | GSK PLC | 3.6% | 1.00M | $38.4M | +0.00%(+0) | — | 2025-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (11 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +32.05% |
| Top 20 Holdings Unweighted | — | — | — | — | +37.62% |
Camber Capital Management Lp reports $1.07B in US-listed equity holdings across 25 positions in its most recent 13F filing. Its largest disclosed positions are SPY (29.0%), ZBH (8.6%) and BAX (8.1%). The top 20 holdings account for 97.85% of reported assets. Its disclosed equity book has returned +32.05% cumulatively over 11 quarters. Figures reflect the Q2 2025 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Camber Capital Management Lp, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Camber Capital Management Lp’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1444043). View Camber Capital Management Lp’s 13F filings on SEC